Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Business

Lancaster University spinout wins major backing to revolutionise healthcare diagnostics

by February 6, 2025
February 6, 2025
Lancaster University spinout wins major backing to revolutionise healthcare diagnostics

Lancaster-based startup CCI Photonics has secured significant new funding to develop its groundbreaking technology for rapid infection detection and antibiotic screening.

Launched by Lancaster University researchers, the spinout aims to deliver test results in as little as 15 minutes—dramatically faster than traditional methods, which can take up to 72 hours.

The investment pot includes £200,000 from the Northern Powerhouse Investment Fund II (NPIF II) PraeSeed programme, £150,000 from the Infection Innovation Consortium (iiCON), and £100,000 from Lyva Labs via Liverpool City Region Combined Authority. CCI Photonics has also received backing from ICURe Innovate UK and holds additional support through a UKRI Novel Technologies Grant.

At the heart of this innovation is InfectiScan, a powerful in vitro diagnostic device that uses infrared spectrometry and advanced AI models to pinpoint bacterial infections in bodily fluids—and determine the most effective antibiotics to prescribe. Founded on research undertaken in partnership with the University Hospitals of Morecambe Bay NHS Foundation Trust (UHMBT), the technology is designed to tackle antibiotic resistance by reducing the guesswork in prescribing antibiotics.

Current diagnostic tools often leave clinicians prescribing treatments on a “best guess” basis, contributing to the rise of antibiotic resistance and increasing the likelihood of ineffective care or infection recurrence. With CCI Photonics’ InfectiScan device, healthcare professionals will be able to rapidly identify pathogens and confirm antibiotic suitability, significantly improving patient outcomes.

Dr Meza Ramirez, Chief Executive of CCI Photonics, emphasised: “This funding allows us to take critical steps in validating and refining our technology. With the support of our partners, we are working to bring a practical solution to healthcare challenges.”

Professor Craig Williams, Consultant Microbiologist at UHMBT, echoed this sentiment: “I hope this ongoing research will provide much more rapid diagnosis, leading to better infection treatment outcomes at a time when bacteria are becoming more resistant to commonly used antibiotics.”

Professor Janet Hemingway, founding director of iiCON, also underlined the importance of disruptive technologies in the fight against infectious diseases, noting the urgent global health challenge and the need for swift innovation.

By combining world-class research, strong funding, and practical clinical collaboration, CCI Photonics is poised to transform infectious disease diagnostics—potentially slashing test turnaround times from days to minutes and helping to stave off the looming threat of antibiotic resistance.

Read more:
Lancaster University spinout wins major backing to revolutionise healthcare diagnostics

0
FacebookTwitterGoogle +Pinterest
previous post
BT scraps diversity targets from managers’ bonuses
next post
Re N Tox: Medical Spa RX Delivers a Breakthrough in Wrinkle Treatment

You may also like

Business leaders paralysed by risk warn BDO as...

June 9, 2025

Ulugbek Shadmanov’s case and UK Investment in Uzbekistan

January 27, 2025

Britain’s biggest companies consider backing new ‘CBI replacement’...

April 22, 2023

Is AI in the Classroom Changing What It...

July 24, 2025

McDonald’s Loses ‘Big Mac’ Trademark Battle Against Irish...

June 6, 2024

DZING Review – the Right App to Manage...

June 16, 2023

Understanding Elon

November 28, 2022

How to plan for the death of a...

August 23, 2023

Jack’s Burgers in Southwold Crowned Best Burger in...

August 5, 2025

Cost of average UK home rises by just...

February 20, 2023

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Trump’s Debanking Order Calls for Investigation, Something Tennessee Should Have Done

      August 7, 2025
    • $93 million in aid to fight malnutrition headed to 12 African countries, Haiti, State Dept says

      August 7, 2025
    • $93 million in aid to fight malnutrition headed to 12 African countries, Haiti, State Dept says

      August 7, 2025
    • America’s Not-So-Secret Secret Police

      August 7, 2025
    • Poll: Nearly 1 in 4 Americans Think They Have a Personal Social Security Account

      August 7, 2025
    • Republican senator claims RFK Jr. mRNA vaccine decision undermines Trump agenda

      August 7, 2025

    Categories

    • Business (8,704)
    • Investing (2,185)
    • Politics (16,335)
    • Stocks (3,228)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved